{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:27:23Z","timestamp":1778056043731,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s12640-009-9079-0","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:11:25Z","timestamp":1248109885000},"page":"66-74","source":"Crossref","is-referenced-by-count":28,"title":["Injectable Hydrogels Providing Sustained Delivery of Vascular Endothelial Growth Factor are Neuroprotective in a Rat Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Dwaine F.","family":"Emerich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Storrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangasamy Suresh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Kordower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"9079_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0361-9230(01)00775-4","volume":"57","author":"J Alberch","year":"2002","unstructured":"Alberch J, Perez-Navarro E, Canals JM (2002) Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington\u2019s disease. Brain Res Bull 57:817\u2013822","journal-title":"Brain Res Bull"},{"key":"9079_CR2","first-page":"195","volume":"146","author":"J Alberch","year":"2004","unstructured":"Alberch J, Perez-Navarro E, Canals JM (2004) Neurotrophic factors in Huntington\u2019s disease. Prog Brain Res 146:195\u2013229","journal-title":"Prog Brain Res"},{"key":"9079_CR3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0306-4522(97)00079-1","volume":"81","author":"DM Araujo","year":"1997","unstructured":"Araujo DM, Hilt D (1997) Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington\u2019s disease. Neuroscience 81:1099\u20131110","journal-title":"Neuroscience"},{"key":"9079_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(97)00266-2","volume":"82","author":"DM Araujo","year":"1998","unstructured":"Araujo DM, Hilt DC (1998) Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid. Neuroscience 82:117\u2013127","journal-title":"Neuroscience"},{"key":"9079_CR5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","volume":"15","author":"J Bloch","year":"2004","unstructured":"Bloch J, Bachoud-L\u00e9vi AC, D\u00e9glon N, Lefaucheur JP, Winkel L, Palfi S, Nguyen JP, Bourdet C, Gaura V, Remy P, Brugi\u00e8res P, Boisse MF, Baudic S, Cesaro P, Hantraye P, Aebischer P, Peschanski M (2004) Neuroprotective gene therapy for Huntington\u2019s disease, using polymer encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 15:968\u2013975","journal-title":"Hum Gene Ther"},{"key":"9079_CR6","doi-asserted-by":"crossref","unstructured":"Bogaert E, Van Damme P, Poesen K, Dhondt J, Hersmus N, Kiraly D, Scheveneels W, Robberecht W, Van Den Bosch L (2009) VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol. Aging Jan 28 epub","DOI":"10.1016\/j.neurobiolaging.2008.12.007"},{"key":"9079_CR7","first-page":"1","volume-title":"Geometri degli indvisibli Tornio","author":"B Cavalieri","year":"1966","unstructured":"Cavalieri B (1966) Geometri degli indvisibli Tornio. Unione Tipografico, Editrice, pp 1\u2013543"},{"key":"9079_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","volume":"494","author":"Y Chu","year":"2006","unstructured":"Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH (2006) Nurr1 in Parkinson disease and related disorders. J Comp Neurol 494:495\u2013514","journal-title":"J Comp Neurol"},{"key":"9079_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/gepi.1370010110","volume":"1","author":"PM Conneally","year":"1984","unstructured":"Conneally PM, Wallace MR, Gusella JF, Wexler NS (1984) Huntington\u2019s disease: estimation of heterozygote status using linked genetic markers. Genet Epidemiol 1:81\u201388","journal-title":"Genet Epidemiol"},{"key":"9079_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1385\/MN:23:2-3:121","volume":"23","author":"SD Croll","year":"2001","unstructured":"Croll SD, Wiegand SJ (2001) Vascular growth factors in cerebral ischemia. Mol Neurobiol 23:121\u2013135","journal-title":"Mol Neurobiol"},{"key":"9079_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3940(92)90092-L","volume":"140","author":"SW Davies","year":"1992","unstructured":"Davies SW, Beardsall K (1992) Nerve growth factor selectively prevents excitotoxin-induced degeneration of striatal cholinergic neurones. Neurosci Lett 140:161\u2013164","journal-title":"Neurosci Lett"},{"key":"9079_CR12","doi-asserted-by":"crossref","first-page":"P433","DOI":"10.1006\/nbdi.2001.0388","volume":"8","author":"LP Almeida de","year":"2001","unstructured":"de Almeida LP, Zala D, Aebischer P, Deglon N (2001) Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington\u2019s disease. Neurobiol Dis 8:P433\u2013P446","journal-title":"Neurobiol Dis"},{"key":"9079_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712598.1.3.467","volume":"1","author":"DF Emerich","year":"2001","unstructured":"Emerich DF (2001) Neuroprotective possibilities for Huntington\u2019s disease. Expert Opin Biol Ther 1:467\u2013479","journal-title":"Expert Opin Biol Ther"},{"key":"9079_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156652306775515547","volume":"6","author":"DF Emerich","year":"2006","unstructured":"Emerich DF, Thanos CG (2006) Intracompartmental delivery of CNTF as therapy for Huntington\u2019s disease and retinitis pigmentosa. Curr Gene Ther 6:147\u2013159","journal-title":"Curr Gene Ther"},{"key":"9079_CR15","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.16-16-05168.1996","volume":"16","author":"DF Emerich","year":"1996","unstructured":"Emerich DF, Winn SR, Lindner MD, Frydel BR, Kordower JH (1996) Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington\u2019s disease. J Neurosci 16:5168\u20135181","journal-title":"J Neurosci"},{"key":"9079_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/386395a0","volume":"386","author":"DF Emerich","year":"1997","unstructured":"Emerich DF, Winn SR, Chen EY, Chu Y, McDermott P, Baetge E, Kordower JH (1997) Protection of basal ganglia circuitry by encapsulated CNTF-producing cells in a primate model of Huntington\u2019s disease. Nature 386:395\u2013399","journal-title":"Nature"},{"key":"9079_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada Sanchez","year":"2008","unstructured":"Estrada Sanchez AM, Mejia-Toiber J, Massieu L (2008) Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease. Arch Med Res 39:265\u2013276","journal-title":"Arch Med Res"},{"key":"9079_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0165-0173(99)00047-8","volume":"2","author":"AA Fienberg","year":"2000","unstructured":"Fienberg AA, Greengard P (2000) The DARPP-32 knockout mouse. Brain Res Brain Res Rev 2:313\u2013319","journal-title":"Brain Res Brain Res Rev"},{"key":"9079_CR19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/10739680802095964","volume":"15","author":"FM Ganhann","year":"2008","unstructured":"Ganhann FM, Popel AS (2008) Systems biology of vascular endothelial growth factors. Microcirculation 15:715\u2013738","journal-title":"Microcirculation"},{"key":"9079_CR20","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase\/Akt signal transduction pathway. Requirement for Flk\/KDR activation. J Biol Chem 273:30336\u201330343","journal-title":"J Biol Chem"},{"key":"9079_CR21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","volume":"78","author":"E Gratacos","year":"2001","unstructured":"Gratacos E, Perez-Navarro E, Tolosa E, Arenas E, Alberch J (2001) Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem 78:1287\u20131296","journal-title":"J Neurochem"},{"key":"9079_CR22","first-page":"685","volume-title":"Neurodegenerative Diseases","author":"JT Greenamyre","year":"1994","unstructured":"Greenamyre JT, Shoulson I (1994) Huntington\u2019s disease. In: Calne D (ed) Neurodegenerative Diseases. Saunders Press, Inc., Philadelphia, pp 685\u2013704"},{"key":"9079_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1013205230142","volume":"3","author":"P Greengard","year":"2001","unstructured":"Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 3:247\u2013269","journal-title":"Biosci Rep"},{"key":"9079_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","volume":"147","author":"H Gundersen","year":"1987","unstructured":"Gundersen H, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229\u2013263","journal-title":"J Microsc"},{"key":"9079_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cardiores.2007.03.028","volume":"75","author":"X Hao","year":"2007","unstructured":"Hao X, Silva E, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Deligren G, Wardell E, Brodin LA, Mooney DJ, Sylven C (2007) Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75:178\u2013185","journal-title":"Cardiovasc Res"},{"key":"9079_CR65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0306-4522(00)00207-4","volume":"99","author":"KL Jin","year":"2000","unstructured":"Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA (2000) Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 99:577\u2013585","journal-title":"Neuroscience"},{"key":"9079_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/neu.20215","volume":"66","author":"K Jin","year":"2006","unstructured":"Jin K, Mao XO, Greenberg DA (2006) Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. J Neurobiol 66:236\u2013246","journal-title":"J Neurobiol"},{"key":"9079_CR27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Conor B (2004) AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a mouse model of Huntington disease. Mol Ther 9:682\u2013688","journal-title":"Mol Ther"},{"key":"9079_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1999.7156","volume":"159","author":"JH Kordower","year":"1999","unstructured":"Kordower JH, Isacson O, Emerich DF (1999) Cellular delivery of trophic factors for the treatment of Huntington\u2019s disease: is neuroprotection possible? Exp Neurol 159:4\u201320","journal-title":"Exp Neurol"},{"key":"9079_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1531-8249(20010201)49:2<202::AID-ANA40>3.0.CO;2-3","volume":"49","author":"JH Kordower","year":"2001","unstructured":"Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ (2001) Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 49:202\u2013213","journal-title":"Ann Neurol"},{"key":"9079_CR30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.WCB.0000126236.54306.21","volume":"24","author":"PS Manoonkitiwongsa","year":"2004","unstructured":"Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF, Lyden PD (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 24:693\u2013702","journal-title":"J Cereb Blood Flow Metab"},{"key":"9079_CR31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","volume":"7","author":"WJ Marks Jr","year":"2008","unstructured":"Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT (2008) Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson\u2019s disease: an open label, phase I study. Lancet Neurol 7:400\u2013408","journal-title":"Lancet Neurol"},{"key":"9079_CR32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.00-0495fje","volume":"15","author":"H Matsuzaki","year":"2001","unstructured":"Matsuzaki H, Tamatani M, Yamaguchi A, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, Tohyama M (2001) FASEB J 15:1218\u20131220","journal-title":"FASEB J"},{"key":"9079_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","volume":"181","author":"JL McBride","year":"2003","unstructured":"McBride JL, During MJ, Wu J, Chen EY, Leurgans SE, Kordower JH (2003) Structural and functional neuroprotection in a rat model of Huntington\u2019s disease by viral gene transfer of GDNF. Exp Neurol 181:213\u2013223","journal-title":"Exp Neurol"},{"key":"9079_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1999.7253","volume":"161","author":"P Menei","year":"2000","unstructured":"Menei P, Pean JM, Nerriere-Daguin V, Jollivet C, Brachet P, Benoit JP (2000) Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp Neurol 161:259\u2013272","journal-title":"Exp Neurol"},{"key":"9079_CR35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","volume":"11","author":"V Mittoux","year":"2000","unstructured":"Mittoux V, Joseph JM, Conde F, Palfi S, Dautry C, Poyot T, Bloch J, Deglon N, Ouary S, Nimchinsky EA, Brouillet E, Hof PR, Peschanski M, Aebischer P, Hantraye P (2000) Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington\u2019s disease. Hum Gene Ther 11:1177\u20131187","journal-title":"Hum Gene Ther"},{"key":"9079_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367","journal-title":"Am J Pathol"},{"key":"9079_CR37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4522(96)00336-3","volume":"75","author":"E Perez-Navarro","year":"1996","unstructured":"Perez-Navarro E, Arenas E, Reiriz J, Calvo N, Alberch J (1996) Glial cell line-derived neurotrophic factor protects striatal calbindin immunoreactive neurons from exitotoxic damage. Neuroscience 75:345\u2013352","journal-title":"Neuroscience"},{"key":"9079_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1460-9568.1999.00433.x","volume":"11","author":"E Perez-Navarro","year":"1999","unstructured":"Perez-Navarro E, Arenas E, Marco S, Alberch J (1999) Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur J NeuroSci 11:241\u2013249","journal-title":"Eur J NeuroSci"},{"key":"9079_CR39","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","volume":"75","author":"E Perez-Navarro","year":"2000","unstructured":"Perez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington\u2019s disease. J Neurochem 75:2190\u20132199","journal-title":"J Neurochem"},{"key":"9079_CR40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2008.12.005","volume":"3","author":"S Ramaswamy","year":"2009","unstructured":"Ramaswamy S, McBride JL, Han I, Berry-Kravis EM, Zhou L, Herzog CD, Gasmi M, Bartus RT, Kordower JH (2009) Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 3:40\u201350","journal-title":"Neurobiol Dis"},{"key":"9079_CR41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2004.01.022","volume":"187","author":"JM Rosenstein","year":"2004","unstructured":"Rosenstein JM, Krum JM (2004) New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187:246\u2013253","journal-title":"Exp Neurol"},{"key":"9079_CR42","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","volume":"3","author":"M Saint-Geniez","year":"2008","unstructured":"Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiuama E, Kurihara T, Darland DC, Young MJ, D\u2019Amore PA (2008) Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS ONE 3:e3554","journal-title":"PLoS ONE"},{"key":"9079_CR43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neures.2008.06.008","volume":"62","author":"S Sathasivam","year":"2008","unstructured":"Sathasivam S (2008) VEGF and ALS. Neurosci Res 62:71\u201377","journal-title":"Neurosci Res"},{"key":"9079_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0891-0618(00)00066-1","volume":"20","author":"C Schmitz","year":"2000","unstructured":"Schmitz C, Hof PR (2000) Recommendations of straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat 20:93\u2013114","journal-title":"J Chem Neuroanat"},{"key":"9079_CR45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","volume":"31","author":"I Shoulson","year":"1981","unstructured":"Shoulson I (1981) Huntington\u2019s disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31:1333\u20131335","journal-title":"Neurology"},{"key":"9079_CR46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1538-7836.2007.02386.x","volume":"5","author":"EA Silva","year":"2007","unstructured":"Silva EA, Mooney DJ (2007) Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5:590\u2013598","journal-title":"J Thromb Haemost"},{"key":"9079_CR47","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0306-4522(98)00540-5","volume":"90","author":"WF Silverman","year":"1999","unstructured":"Silverman WF, Krum JM, Mani N, Rosenstein JM (1999) Vascular, glial, and neuronal effects of vascular endothelial growth factor in mesencephalic explants cultures. Neuroscience 90:1529\u20131541","journal-title":"Neuroscience"},{"key":"9079_CR48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-8993(99)02056-9","volume":"846","author":"M Sondell","year":"1999","unstructured":"Sondell M, Lundborg G, Kanje M (1999) Vascular endothelial growth factor stimulates Schwaan cell invasion and neovascularization of acellular nerve grafts. Brain Res 846:219\u2013228","journal-title":"Brain Res"},{"key":"9079_CR49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","volume":"26","author":"E Storkebaum","year":"2004","unstructured":"Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943\u2013954","journal-title":"Bioessays"},{"key":"9079_CR50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jnr.20321","volume":"79","author":"FY Sun","year":"2005","unstructured":"Sun FY, Guo X (2005) Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79:180\u2013184","journal-title":"J Neurosci Res"},{"key":"9079_CR51","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.wcb.0000037988.07114.98","volume":"22","author":"B Svensson","year":"2002","unstructured":"Svensson B, Peters M, Konig HG, Poppe M, Levkau B, Rothermundt M, Arolt V, Kogel D, Prehn JH (2002) Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab 22:1170\u20131175","journal-title":"J Cereb Blood Flow Metab"},{"key":"9079_CR52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013978","journal-title":"Cell"},{"key":"9079_CR53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neulet.2007.05.033","volume":"421","author":"Y Tian","year":"2007","unstructured":"Tian Y, Tang CJ, Wang JN, Feng XW, Wang L, Qiao X, Sun SG (2007) Favorable effects of VEGF gene transfer on a rat model of Parkinsons disease using adeno-associated viral vectors. Neurosci Lett 421:239\u2013244","journal-title":"Neurosci Lett"},{"key":"9079_CR54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.2007.05206.x","volume":"105","author":"L Tolosa","year":"2008","unstructured":"Tolosa L, Mir M, Asensio VJ, Olmos G, Llado J (2008) Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem 105:1080\u20131090","journal-title":"J Neurochem"},{"key":"9079_CR55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/nen.0b013e3181567c16","volume":"66","author":"LB Tovar-Y-Romo","year":"2007","unstructured":"Tovar-Y-Romo LB, Zepeda A, Tapia R (2007) Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J Neuropathol Exper Neurol 66:913\u2013922","journal-title":"J Neuropathol Exper Neurol"},{"key":"9079_CR56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1535-7511.2008.00269.x","volume":"8","author":"A Vezzani","year":"2008","unstructured":"Vezzani A (2008) VEGF as a target for neuroprotection. Epilepsy Curr 8:135\u2013137","journal-title":"Epilepsy Curr"},{"key":"9079_CR57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1523\/JNEUROSCI.4433-06.2007","volume":"27","author":"Y Wang","year":"2007","unstructured":"Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K (2007) Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis. J Neurosci 27:304\u2013307","journal-title":"J Neurosci"},{"key":"9079_CR58","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482\u2013497","journal-title":"Anat Rec"},{"key":"9079_CR59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O","volume":"370","author":"MJ West","year":"1996","unstructured":"West MJ, Ostergaard K, Andreassen OA, Finsen B (1996) Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 370:11\u201322","journal-title":"J Comp Neurol"},{"key":"9079_CR60","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.22-15-06401.2002","volume":"22","author":"A Wick","year":"2002","unstructured":"Wick A, Wick W, Walternberger J, Weller M, Dichgans J, Schulz JB (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neuroscience 22:6401\u20136407","journal-title":"J. Neuroscience"},{"key":"9079_CR61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3727\/000000007783464632","volume":"16","author":"T Yasuhara","year":"2007","unstructured":"Yasuhara T, Date I (2007) Intracerebral transplantation of genetically engineered cells for Parkinsons disease: toward clinical application. Cell Transpl 16:125\u2013132","journal-title":"Cell Transpl"},{"key":"9079_CR62","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","volume":"19","author":"T Yasuhara","year":"2004","unstructured":"Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I (2004) Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parksinson\u2019s disease. Eur J NeuroSci 19:1494\u20131504","journal-title":"Eur J NeuroSci"},{"key":"9079_CR63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.05.027","volume":"1053","author":"T Yasuhara","year":"2005","unstructured":"Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I (2005) Neurorescue effects of VEGF on a rat model of Parkinson\u2019s disease. Brain Res 1053:10\u201318","journal-title":"Brain Res"},{"key":"9079_CR64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/096368970000900404","volume":"9","author":"AD Zurn","year":"2000","unstructured":"Zurn AD, Henry H, Schluep M, Aubert V, Winkel L, Eilers B, Bachmann C, Aebischer P (2000) Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell Transplant 9:471\u2013484","journal-title":"Cell Transplant"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-009-9079-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9079-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:31:13Z","timestamp":1559482273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-009-9079-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["9079"],"URL":"https:\/\/doi.org\/10.1007\/s12640-009-9079-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]}}}